Pfizer-BioNTech Develops More Effective Vaccine Against Omicron

emerging in 2020 COVID-19 The pandemic had taken the world by storm for a long time. The disease, which caused the death of millions of people, managed to turn our lives upside down for almost two years. emerging towards the end of 2021. Omicronvariant made the epidemic worse, causing some countries to increase restrictions.

Fortunately, the effects of the epidemic were reduced with the help of the measures taken, especially the vaccine, and the mask requirement was removed. One of those who play an important role in the fight against the pandemic. Pfizer-BioNTech It was a vaccine developed by Now, new statements have come from these two companies about the vaccine.

More effective vaccines developed against Omicron

fc3313370e2fa7501e6fbfff8b9e7e4d8c058aa8

Pfizer-BioNTech announced that they have developed a more effective vaccine against the Omicron variant. In the statements made on the official website, it was observed that the updated COVID-19 vaccines showed more immunity than the original vaccine.

According to the descriptions, only Omicron targeting the variantor other vaccine variant protection adding Two methods, one enhancer, were tested by researchers at Pfizer-BioNTech. It was reported that two different doses of 30 and 60 micrograms were tested in more than 1200 adults over the age of 56.

The results obtained as a result show that both vaccines are more effective against the variant than the original vaccine. higher immune response revealed that it did. It was also stated that a significant increase in antibodies was observed.

Pfizer CEO Albert BourlaIn his statements on the subject, he said, “ As we have said since day one of the pandemic, we will follow the science as the virus evolves and try to apply our own approaches to it. Based on these data, variant-adapted compounds elicited a much higher immune response to Omicron than we have seen to date. two very strong vaccinesWe believe we are our candidate.” he said.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *